Orthofix Medical, Inc.
http://www.orthofix.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Orthofix Medical, Inc.
Deal Watch: Sol-Gel To Tackle Gorlin Syndrome In Pact With BridgeBio’s PellePharm
Shoreline picks up technology platform rights and access from Editas, which recently reduced staff. Hyloris out-licenses commercial rights to Maxigesic in nine EU markets to Salus.
Orthofix And SeaSpine Plan Merger To Create Billion-Dollar Spine And Ortho Company
The “merger of equals” will bring together complementary spine surgery and orthopedic products including spine implants, biologics, limb-reconstruction devices and surgical planning and navigation software.
NuVasive Adds Artificial Cervical Disc By Acquiring Simplify For $150M
Simplify’s total disc replacement complements NuVasive’s C360 line of cervical repair surgery devices, addressing a market that could eventually be worth $2.6bn.
Market Brief: Orthobiologics Market Will See Modest Growth By 2024, Stimulated By Growth Factors
Global sales of orthobiologics products are expected to reach $2.8bn by 2024, a CAGR of 3.2%, led by the rising aging population and musculoskeletal disease.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Other Names / Subsidiaries
-
- Blackstone
- Orthofix International N.V.
- Options Medical, LLC
- SeaSpine Holdings Corporation
- Spinal Kinetics, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice